CTSA Archives
VUMC Announces VICTR Leadership Transition
Dec. 16, 2022—by Bill Snyder Gordon Bernard, MD, a leader in clinical and translational medicine at Vanderbilt University Medical Center for more than 40 years, will step aside from his institutional leadership roles in July 2023 to focus more on his research interests and allow a new generation of leaders to take center stage. Bernard, the Melinda...
Study supports removing race from estimate of kidney function
Nov. 17, 2022—An in-depth analysis by Vanderbilt investigators of published research studies supports removing race from the calculation of estimated glomerular filtration rate (eGFR) — an assessment of kidney function.
Self named co-principal investigator of Vanderbilt’s Clinical and Translational Science Award
Sep. 22, 2022—Wesley Self, MD, MPH, a physician-scientist at Vanderbilt University Medical Center, has been named co-principal investigator (co-PI) of Vanderbilt’s Clinical and Translational Science Award (CTSA).
Major grant renewal to provide five more years of support for VICTR
Apr. 6, 2022—Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.
VUMC awarded $34 million to lead nationwide convalescent plasma study
Aug. 21, 2020—Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
Wilkins named CTSA co-principal investigator
Jan. 16, 2020—Consuelo Wilkins, MD, MSCI, has joined Gordon Bernard, MD, as co-principal investigator of Vanderbilt’s Clinical and Translational Science Award.
Heat a trigger for seizures
Sep. 6, 2017—Elevated body temperature alone can increase vulnerability to fever-induced seizures, even in the absence of infection or inflammation.
Pain and Alzheimer’s disease
Sep. 5, 2017—Clinicians should use a structured interview in people with Alzheimer’s disease to identify pain that might be otherwise overlooked.
VUMC lands renewal of Clinical and Translational Science Award
Jun. 8, 2017—Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).
Superior scan for tumors
Jun. 24, 2016—Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors.
Children, heart disease, and IQ
Nov. 16, 2015—Treatment for congenital heart disease during infancy may result in cognitive and attentional deficits during adolescence and young adulthood, Vanderbilt researchers have found.
Revised regulations proposed for human subject research
Oct. 22, 2015—Eighteen departments and agencies of the federal government have joined to propose revised regulations for scientific research involving human subjects.
